The story of Sildenafil presents a complex picture for those considering investment. While the initial introduction generated substantial returns, the expiration of its patent opened the door to cheaper alternatives, https://liviadfew175085.jts-blog.com/40387985/sildenafil-and-big-pharma-a-volatile-opportunity